Cardioplegia in Open Heart Surgery: Age Matters
Journal of Clinical Medicine · 20.02.2023 · 12 (4) · 1698
DOI: 10.3390/jcm12041698 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 20.02.2023. Verfasst von Jovana Bradić und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Faculty of Medical Sciences, University of Kragujevac, Svetozara Markovica 69, 34000 Kragujevac, Serbia. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Cardioplegia is a pharmacological approach essential for the protection of the heart from ischemia–reperfusion (I–R) injury. Over the years, numerous cardioplegic solutions have been developed, with each cardioplegic approach having its advantages and disadvantages. Cardioplegic solutions can be divided into crystalloid and blood cardioplegic solutions, and an experienced surgeon chooses the type of solution based on the individual needs of patients in order to provide optimal heart protection. Importantly, the pediatric immature myocardium is structurally, physiologically, and metabolically different from the adult heart, and consequently its needs to achieve cardioplegic arrest strongly differ. Therefore, the present review aimed to provide a summary of the cardioplegic solutions available to pediatric patients with a special focus on emphasizing differences in heart injury after various cardioplegic solutions, the dosing strategies, and regimens. Material and methods: The PubMed database was searched using the terms cardioplegia, I–R, and pediatric population, and studies that investigated the influence of cardioplegic strategies on markers of cardiac muscle damage were further analyzed in this review.
Conclusions
A large body of evidence suggested more prominent benefits achieved with blood compared to those with crystalloid cardioplegia in pediatric myocardium preservation. However, standardized and uniform protocols have not been established so far, and an experienced surgeon chooses the type of cardioplegia solution based on the individual needs of patients, while the severity of myocardial damage strongly depends on the type and duration of the surgical procedure, overall patient condition, and presence of comorbidities, etc.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, Faculty of Medical Sciences, University of Kragujevac, Svetozara Markovica 69, 34000 Kragujevac, Serbia.
- Center of Excellence for Redox Balance Research in Cardiovascular and Metabolic Disorders, Svetozara Markovica 69, 34000 Kragujevac, Serbia.
- 1st Moscow State Medical, University IM Sechenov, Trubetskaya 8/2, 119991 Moscow, Russia.
- Department of Physiology, Faculty of Medical Sciences, University of Kragujevac, Svetozara Markovica 69, 34000 Kragujevac, Serbia.
- Department of Human Pathology, 1st Moscow State Medical, University IM Sechenov, Trubetskaya 8/2, 119991 Moscow, Russia.
ORCID-Profile: Jovana Bradić, Jovana Novaković, Vladimir Jakovljević
Zitieren
APA
Bradić, J., Andjić, M., Novaković, J., Jeremić, N., & Jakovljević, V. (2023). Cardioplegia in Open Heart Surgery: Age Matters. Journal of Clinical Medicine, 12(4), 1698. https://doi.org/10.3390/jcm12041698
Vancouver
Bradić J, Andjić M, Novaković J, Jeremić N, Jakovljević V. Cardioplegia in Open Heart Surgery: Age Matters. Journal of Clinical Medicine. 2023;12(4):1698. doi:10.3390/jcm12041698
BibTeX
@article{Bradi2023,
author = {Bradić, Jovana and Andjić, Marijana and Novaković, Jovana and Jeremić, Nevena and Jakovljević, Vladimir},
title = {Cardioplegia in Open Heart Surgery: Age Matters},
journal = {Journal of Clinical Medicine},
year = {2023},
volume = {12},
number = {4},
pages = {1698},
doi = {10.3390/jcm12041698}
}
EUVIMED